Physician profile
Vikram Agarwal
NPI 1942501044
$9,067.22
in general payments reported to CMS, 2019-2025
43 companies · $1,282 in 2025
The $1,282 reported for 2025 was more than what 75% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,359 · 2020: $359 · 2021: $1,680 · 2022: $1,071 · 2023: $1,573 · 2024: $744 · 2025: $1,282.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,598.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,459.40 | 2019-2025 | Ffrct |
| Boston Scientific Corporation | $945.98 | 2019-2023 | Watchman Access System |
| Novartis Pharmaceuticals Corporation | $828.77 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $572.92 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $519.66 | 2021-2025 | Farxiga, Wainua |
| Aop Health US, LLC | $515.87 | 2025 | Rapiblyk |
| Merck Sharp & Dohme LLC | $481.82 | 2021-2025 | Verquvo |
| Astellas Pharma US INC | $370.72 | 2019-2020 | |
| Abbott Laboratories | $311.21 | 2021-2022 | |
| Amgen INC. | $304.28 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $295.74 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $237.02 | 2019-2024 | Xarelto |
| Amarin Pharma, INC. | $228.92 | 2019-2021 | |
| Shockwave Medical, INC | $185.65 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Regeneron Healthcare Solutions, INC. | $176.16 | 2019-2020 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.